Literature DB >> 35913527

Comparative analysis of bilirubin glucuronidation activity in canine and human primary hepatocytes using a 3D culture system.

Hisayoshi Omori1,2, Junko Chikamoto2, Takayuki Hirano2, Kazuhiko Besshi3, Naoaki Yoshimura1, Maki Hirata1,4, Takeshige Otoi5,6.   

Abstract

Species differences in bilirubin glucuronidation activity are observed between humans and dogs through liver microsomes and recombinant UDP-glucuronosyltransferase 1A1. Humans exhibit higher activity than that of dogs. In this study, bilirubin glucuronidation activity was examined in canine and human primary hepatocyte spheroids formed using a 3D culture system. When spheroid development in canine and human primary hepatocytes was evaluated on days 7 and 14 after the start of culture, canine primary hepatocyte spheroids had a more distinct spherical shape than human hepatocyte spheroids, irrespective of the culture period. Furthermore, mono- and di-glucuronide generation detected in spheroids were significantly higher (P < 0.05) in human primary hepatocytes than in canine primary hepatocytes after 24 h of incubation with bilirubin for each culture period. These results suggest that there are species differences in the bilirubin glucuronidation activity of primary hepatocytes with spheroid formation between humans and dogs, with the activity being higher in humans than in dogs.
© 2022. The Society for In Vitro Biology.

Entities:  

Keywords:  Bilirubin glucuronidation; Dog; Human; Primary hepatocyte; Spheroid

Mesh:

Substances:

Year:  2022        PMID: 35913527     DOI: 10.1007/s11626-022-00711-9

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.723


  24 in total

Review 1.  Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies.

Authors:  Nicola J Hewitt; María José Gómez Lechón; J Brian Houston; David Hallifax; Hayley S Brown; Patrick Maurel; J Gerald Kenna; Lena Gustavsson; Christina Lohmann; Christian Skonberg; Andre Guillouzo; Gregor Tuschl; Albert P Li; Edward LeCluyse; Geny M M Groothuis; Jan G Hengstler
Journal:  Drug Metab Rev       Date:  2007       Impact factor: 4.518

Review 2.  An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons.

Authors:  Esther F A Brandon; Christiaan D Raap; Irma Meijerman; Jos H Beijnen; Jan H M Schellens
Journal:  Toxicol Appl Pharmacol       Date:  2003-06-15       Impact factor: 4.219

3.  Comparative analysis of bilirubin glucuronidation activity in 2D- and 3D-cultured human hepatocellular carcinoma HepG2 cells.

Authors:  Takayuki Hirano; Maki Hirata; Shigeyuki Fujimoto; Nhien Thi Nguyen; Quynh Anh Le; Fuminori Tanihara; Takeshige Otoi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2020-05-11       Impact factor: 2.416

4.  Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolites.

Authors:  Deepak Dalvie; R Scott Obach; Ping Kang; Chandra Prakash; Cho-Ming Loi; Susan Hurst; Angus Nedderman; Lance Goulet; Evan Smith; Hai-Zhi Bu; Dennis A Smith
Journal:  Chem Res Toxicol       Date:  2009-02       Impact factor: 3.739

5.  Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome.

Authors:  S Aono; Y Adachi; E Uyama; Y Yamada; H Keino; T Nanno; O Koiwai; H Sato
Journal:  Lancet       Date:  1995-04-15       Impact factor: 79.321

6.  Hepatic microsomal bilirubin UDP-glucuronosyltransferase. The kinetics of bilirubin mono- and diglucuronide synthesis.

Authors:  J M Crawford; B J Ransil; J P Narciso; J L Gollan
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

Review 7.  Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences.

Authors:  Serge Erlinger; Irwin M Arias; Daniel Dhumeaux
Journal:  Gastroenterology       Date:  2014-04-01       Impact factor: 22.682

8.  The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.

Authors:  P J Bosma; J R Chowdhury; C Bakker; S Gantla; A de Boer; B A Oostra; D Lindhout; G N Tytgat; P L Jansen; R P Oude Elferink
Journal:  N Engl J Med       Date:  1995-11-02       Impact factor: 91.245

9.  Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes.

Authors:  Lei Guo; Stacey Dial; Leming Shi; William Branham; Jie Liu; Jia-Long Fang; Bridgett Green; Helen Deng; Jim Kaput; Baitang Ning
Journal:  Drug Metab Dispos       Date:  2010-12-13       Impact factor: 3.922

10.  Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease.

Authors:  Catherine C Bell; Delilah F G Hendriks; Sabrina M L Moro; Ewa Ellis; Joanne Walsh; Anna Renblom; Lisa Fredriksson Puigvert; Anita C A Dankers; Frank Jacobs; Jan Snoeys; Rowena L Sison-Young; Rosalind E Jenkins; Åsa Nordling; Souren Mkrtchian; B Kevin Park; Neil R Kitteringham; Christopher E P Goldring; Volker M Lauschke; Magnus Ingelman-Sundberg
Journal:  Sci Rep       Date:  2016-05-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.